Navigation Links
Assay Designs(TM) Announces Collaboration with Medical University of South Carolina (MUSC)
Date:5/5/2008

ANN ARBOR, Mich., May 5 /PRNewswire/ -- Assay Designs, Inc., a leading provider of immunoassay kits, antibodies, and reagents to the life sciences and translational research markets, announced a collaboration on a joint antibody research project with the Medical University of South Carolina and Dr. Jennifer Isaacs' laboratory. Under the terms of this agreement, Assay Designs will provide anti-Heat shock protein 90 (Hsp90) antibody for both cell-based and animal-based work.

This collaboration agreement will allow Dr. Isaacs to move forward with research investigating the role of Hsp90 in the progression of many cancers. "I am excited about the prospect of utilizing this antibody to target the Hsp90 chaperone and to potentially curtail the metastatic properties of some cancers. Moreover, we now have a new tool to explore the role of cell surface localized Hsp90 protein in cancer progression. Since this antibody is well-tolerated in animals, this approach paves the way for a promising therapeutic strategy, " stated Dr. Isaacs.

"As the leader in heat shock proteins (HSPs) and chaperones, collaborations such as this provide valuable insight for our new product development efforts," stated Dan Calvo, Assay Designs' President and CEO. "Supporting the validation of new and novel test protocols enhances the value and flexibility of our broad HSP product portfolio."

About Assay Designs, Inc.

Based in Ann Arbor, MI, Assay Designs develops, manufactures and markets immunoassay (ELISA) kits, antibodies, and proteins that are used for life sciences research. The company markets these products under the "Assay Designs" and "Stressgen" brand names. Researchers use Assay Designs products to detect and quantify molecules that are important biomarkers of inflammation, heat shock, cell signaling, and oxidative stress.

About Isaacs Lab.

A long-term research goal of the Isaacs Lab is to better understand the role of Hsp90 in tumor progress
'/>"/>

SOURCE Assay Designs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics
2. Genetic Engineering & Biotechnology News reports on growing use of cell-based assays
3. Genetic Engineering & Biotechnology News Reports on Growing Use of Cell-Based Assays
4. Cellix Ltd. Launches VenaEC Biochip for Flow-based Cell-adhesion Assays
5. Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program
6. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
7. Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity
8. Cellix Ltd. Launches the First Semi-Automated, High Throughput Cell-Adhesion Assay Platform
9. A New, Unique and Unrivalled Rat/Mouse PINP Assay for Pharmaceutical, Clinical and Academic Research Organizations.
10. Study Reaffirms Superiority of Trofile(TM) Assay
11. EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... The world,s first concept demonst... breakthrough alternative to replace a petrochemic...thetic rubber with renewable biomass, made their d...ill be on display at a lounge in the common depart...hroughout December 21, while the other tire will m...
(Date:12/2/2009)...ss., Dec. 2 TechConnect World, an ...development and product integration in cleantech, ... 11th deadline for technology abstracts and busine...Connect World, in association with the Nano Scienc...echnology and Sustainable Industries Organization ...
(Date:12/2/2009)... /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (N... biopharmaceutical company focused on endocrine th...Food and Drug Administration (FDA) has granted Fas...hway inhibitor compound, perifosine (KRX-0401), fo...eloma. Keryx Biopharmaceuticals, Inc. ("Keryx") ( ...
(Date:12/1/2009)...., Dec. 1 PDL BioPharma,...ue guidance for the fourth quarter ended December ... with $69 million for the fourth quarter of 2008. ...rst of two installment payments of $12.5 million f... results was a one-time $1.8 million payment from ...
Breaking Biology Technology:The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...24 /PRNewswire-Asia-FirstCall/ -- China Sky One,Me...ny") (Nasdaq: CSKI ), a,leading fully integrated...,drugs in the People,s Republic of China ("PRC"), ...Peng Lai Jin Chuang Pharmaceutical Company ("Jin,C...t with Shaanxi Buchang,Group ("Buchang") for Nafto...
...wswire-FirstCall/ - Angiotech Pharmaceuticals, Inc...pharmaceutical and medical device company, today a...ear end conference call. The call will take place ...2009. , , , Dial information for the earnings ...s follows:, North America (toll-free): (800) 29...
... 24 Novasys Medical, Inc., a developer,of innovat...hat Noridian,Administrative Services, LLC, a regio...e states, is now covering the non-surgical Renessa...nce (SUI). Noridian currently,administers benefit...es in,Alaska, Arizona, Montana, North and South Da...
Other Biology Technology:China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets 2China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets 3Noridian Medicare Now Covers Renessa(R) Treatment for Incontinence in Women 2
(Date:12/3/2009)...80s, Harald zur Hausen and his co-workers discover...V) cause cervical cancer. Scientists soon found ou...t is known today that the main culprits are viral ...rent cellular control functions, thus promoting ce...-workers at DKFZ have now discovered another mecha...
(Date:12/3/2009)...HIA Now in its 32nd year, the CTRC-AACR San Anton...e best in breast cancer science and world leaders ...ating breast cancer. , This year, more than 8,5...at the Henry B. Gonzales Convention Center in San ...artnership between the American Association for Ca...
(Date:12/3/2009)...ellers must be included in the design of the upcom...humanitarian crisis, according to a scientist at t...ure , Dr Simon Lewis argues that at least 50% of t...en, known as REDD (Reducing Emissions from Defores...dwellers directly, and their property rights assur...
Breaking Biology News(10 mins):Papillomavirus silences innate immune response 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2New Walking Program Website Inspires Americans to Step Out and Step Up to Better Health 57058 1New Walking Program Website Inspires Americans to Step Out and Step Up to Better Health 57058 2American Imaging Management Selected to Deliver Diagnostic Imaging Management Services for ODS Health Plan 57055 1American Imaging Management Selected to Deliver Diagnostic Imaging Management Services for ODS Health Plan 57055 2Ronald O Perelman Heart Institute of NewYork Presbyterian Hospital Weill Cornell Medical Center Opens as a Center for Innovative World Class Cardiac 57052 1Ronald O Perelman Heart Institute of NewYork Presbyterian Hospital Weill Cornell Medical Center Opens as a Center for Innovative World Class Cardiac 57052 2Ronald O Perelman Heart Institute of NewYork Presbyterian Hospital Weill Cornell Medical Center Opens as a Center for Innovative World Class Cardiac 57052 3Ronald O Perelman Heart Institute of NewYork Presbyterian Hospital Weill Cornell Medical Center Opens as a Center for Innovative World Class Cardiac 57052 4Ronald O Perelman Heart Institute of NewYork Presbyterian Hospital Weill Cornell Medical Center Opens as a Center for Innovative World Class Cardiac 57052 5
... St. Jude Children,s Research Hospital have discov... ready to change its identity that it requires the...suade it. , The researchers showed that Prox1 ac...ent to reprogram a specialized type of cell, calle...ce of active Prox1, the LEC actually loses its ide...
...ow demonstrate how a tight junction protein called...g fit. The study will be published in the December...www.jcb.org ). , Like the rubber coating on a cop... glial cells that spirals around the axons of neur...nt leakage from axons and aids electrical conducti...
... Latina women have a lower risk of breast cancer t...but those with higher European ancestry could be a...he December 1 issue of Cancer Research , a journa... , "We need to study the possible factors that ar...t greater risk," said Laura Fejerman, Ph.D., a pos...
Other Biology News:Reprogrammable cell type depends on a single gene to keep its identity 2European ancestry increases breast cancer risk among Latinas 2
Combination Roto Shake Genie from Femto Scientific
GIBCO MarrowMAX Bone Marrow Medium from Invitrogen
Rat Adrenal from Pel-Freez Biologicals
GIBCO CMRL Medium-1066 (1X) liquid from Invitrogen
Biology Products: